Effect of drugs on the driving performance;Beeinflussung der fahrtüchtigkeit durch arzneimittel

Internist

Volumn 43, Issue 7, 2002, Pages 889-898

  Mörike, Klaus ^a   Gleiter, C H ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA INTERFERON; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANXIOLYTIC AGENT; CAFFEINE; CENTRAL STIMULANT AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; DIHYDROERGOTAMINE; GLUCOCORTICOID; GOSERELIN; HYPNOTIC AGENT; IPRATROPIUM BROMIDE; LEUPRORELIN; MEDROXYPROGESTERONE; METHYLDOPA; METHYLPHENIDATE; NEUROTROPIC AGENT; ORAL CONTRACEPTIVE AGENT; PIRACETAM; RESERPINE; SALMETEROL; SEDATIVE AGENT; TERBUTALINE; THEOPHYLLINE; THYROXINE; UNINDEXED DRUG; XANTHINE DERIVATIVE;

DRIVING ABILITY; DRUG EFFECT; HUMAN; REVIEW; TASK PERFORMANCE;

AUTOMOBILE DRIVING; GERMANY; HUMANS; PHARMACEUTICAL PREPARATIONS; PSYCHOMOTOR PERFORMANCE; RISK FACTORS;

EID: 18244422671     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-002-0657-y     Document Type: Review

References (68)

1. Amoroso PJ, Reynolds KL, Bell NS et al. (1998) Benzodiazepine use and crash risk in older patients. JAMA 279: 113-115
2. Arzneimittelkommission der deutschen Ärzteschaft (1999) Einschlafattacken am tage unter dopaminergen anti-parkinson-medikamenten. Dtsch Arztebl 96: A-3200
3. Barbone F, McMahon AD, Davey PG, Morris AD, Reid IC, McDevitt DG, MacDonald TM (1998) Association of road-traffic accidents with benzodiazepine use. Lancet 352: 1331-1136
4. Brodie MJ, Dichter MA (1996) Antiepileptic drugs. N Engl J Med 334: 168-175
5. Bundesanstalt für Straßenwesen (2000) Begutachtungs-leitlinien zur kraftfahrereignung. Berichte der bundesanstalt für straßenwesen. Mensch und Sicherheit, Heft M 115. Bast, Bergisch Gladbach
6. Comella CL (2002) Daytime sleepiness, agonist therapy, and driving in Parkinson disease. JAMA 287: 509-511
7. Cox DJ, Gonder-Frederick LA, Kovatchev BP, Julian DM, Clarke WL (2000) Progressive hypoglycemia's impact on driving simulation performance: Occurrence, awareness, and correction. Diabetes Care 23: 163-170
8. Cox DJ, Merkel RL, Kovatchev B, Seward R (2000) Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder. A preliminary double-blind placebo controlled trial. J Nerv Ment Dis 188: 230-234
9. Dalén P, Alván G, Wakelkamp M, Olsen H (1996) Formation of meprobamate from carisoprodol is catalysed by CYP2C19. Pharmacogenetics 6: 387-394
10. De Waard D, Brookhuis KA, Lee TH et al. (2000) Drug effects on driving performance. Ann Intern Med 133: 656-658
11. Eadie MJ (2001) Therapeutic drug monitoring - Antiepileptic drugs. Br J Clin Pharmacol 52 (Suppl): 11S-20S]
12. Edwards JG (1995) Depression, antidepressants, and accidents. BMJ 311: 887-888
13. Fachinformation Lioresal®
14. Fachinformation Musaril®
15. Feely M (1999) Drug treatment of epilepsy. BMJ 318: 106-109
16. Foley DJ, Wallace RB, Eberhard J (1995) Risk factors for motor vehicle crashes among older drivers in a rural community. J Am Geriatr Soc 43: 776-781
17. Frier BM (2000) Hypoglycemia and driving performance. Diabetes Care 23: 148-150
18. Frucht S, Rogers JD, Greene PE, Gordon MF, Fahn S (1999) Falling asleep at the wheel: Motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 52: 1908-1910
19. Hanks GW (1995) Morphine sans morpheus. Lancet 346: 652-653
20. Hauser RA, Gauger L, Anderson WM, Zesiewicz TA (2000) Pramipexole-induced somnolence and episodes of daytime sleep. Mov Disord 15: 658-663
21. Hemmelgarn B, Suissa S, Huang A, Boivin JF, Pinard G (1997) Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA 278: 27-31
22. Hennessy S, Strom BL (2000) Nonsedating antihistamines should be preferred over sedating antihistamines in patients who drive. Ann Intern Med 132: 405-7
23. Hobson DE, Lang AE, Martin WRW, Razmy A, Rivest J, Fleming J (2002) Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease. JAMA 287: 455-463
24. Hu PS, Trumble DA, Foley DJ, Eberhard JW, Wallace RB (1998) Crash risk of older drivers: A panel data analysis. Accid Anal Prev 30: 569-581
25. Jonasson U, Jonasson B, Saldeen T, Thuen F (2000) The prevalence of analgesics containing dextropropoxyphene or codeine in individuals suspected of driving under the influence of drugs. Forensic Sci Internat 112: 163-169
26. Klotz U, Laux G (1996) Tranquillantien. Therapeutischer Einsatz und Pharmakologie, 2. Aufi. Wiss. Verlagsgesellschaft, Stuttgart
27. Krauss GL, Krumholz A, Carter RC, Li G, Kaplan P (1999) Risk factors for seizure-related motor vehicle crashes in patients with epilepsy. Neurology 52: 1324-1329
28. Krumholz A, Fisher RS, Lesser RP, Hauser WA 1991) Driving and epilepsy. A review and reappraisal. JAMA 265: 622-626
29. Kupfer DJ, Reynolds CF (1997) Management of insomnia. N Engl J Med 336: 341-346
30. Kwan K, Brodie MJ (2001) Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 357: 216-222
31. Lader M (1997) Psychiatric disorders. In: Speight TM, Holford NHG (eds) Avery's Drug Treatment, 4th Edn. Adis, Auckland
32. Larsen JP, Tandberg E (2001) Sleep disorders in patients with Parkinson's disease: Epidemiology and management. CNS Drugs 15: 267-275
33. Leveille SG, Buchner DM, Koepsell TD, McCloskey LW, Wolf ME, Wagner EH (1994) Psychoactive medications and injurious motor vehicle collisions involving older drivers. Epidemiology 5: 591-598
34. Logan BK, Case GA, Gordon AM (2000) Carisoprodol, meprobamate, and driving impairment. J Forensic Sci 45: 619-623
35. Logan BK, Couper FJ (2001) Zolpidem and driving impairment. J Forensic Sci 46: 105-110
36. Longo M, Hunter CE, Lokan RJ, White JM, White MA (2000) The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability. Part I: The prevalence of drug use in drivers, and characteristics of the drug-positive group. Accid Anal Prev 32: 613-622
37. Longo M, Hunter CE, Lokan RJ, White JM, White MA (2000) The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability. Part II: The relationship between drug prevalence and drug concentration, and driver culpability. Accid Anal Prev 32: 623-632
38. Lyznicki JL, Doege TC, Davis RM, Williams MA, for the Council on Scientific Affairs, American Medical Association (1998) Sleepiness, driving, and motor vehicle crashes. JAMA 279: 1908-1913
39. Mann RD, Pearce GL, Dunn N, Shakir S (2000) Sedation with "non-sedating" antihistamines: Four prescription-event monitoring studies in general practice. BMJ 320: 1184-1187
40. Marrero D, Edelman S (2000) Hypoglycemia and driving performance. Diabetes Care 23: 146-147
41. Mattila MJ, Paakkari I (1999) Variations among non-sedating antihistamines: Are there real differences? Eur J Clin Pharmacol 55: 85-93
42. McGwin G, Sims RV, Pulley L, Roseman JM (1999) Diabetes and automobile crashes in the elderly. A population-based case-control study. Diabetes Care 22: 220-227
43. McGwin G, Sims RV, Pulley L, Roseman JM (2000) Relations among chronic medical conditions, medications, and automobile crashes in the elderly: A population-based case-control study. Am J Epidemiol 152: 424-431
44. Meijler WJ (2000) Driving ban for patients on chronic opioid therapy unfounded. Ned Tijdschr Geneesk 144: 1644-1645
45. Möller JC, Stiasny K, Cassel W, Peter JH, Krüger HP, Oertel WH (2000) "Schlafattacken" bei parkinson-patienten. Eine nebenwirkung von nonergolin-dopaminagonisten oder ein klasseneffekt von dopamimimetika? Nervenarzt 71: 670-676
46. Neutel CI (1995) Risk of traffic accident injury after a prescription for a benzodiazepine. Ann Epidemiol 5: 239-244
47. Novak AJ, Krumholz A, Fisher RS, Lesser RP, Hauser WA (1991) Driving and epilepsy: The effects of medication. JAMA 265: 2961-2962
48. Olanow CW, Schapira AHV, Roth T et al. (2000) Falling asleep at the wheel: Motor vehicle mishaps in people taking pramipexole and ropinirole. Neurology 54: 274-277
49. Ondo WG, Dat Vuong K, Khan H, Atassi F, Kwak C, Jankovic J (2001) Daytime sleepiness and other sleep disorders in Parkinson's disease. Neurology 57: 1392-1396
50. O'Hanlon JF (1988) Antihistamines and driving safety. Cutis 42: 10-13
51. O'Hanlon JF, Ramaekers JG (1995) Antihistamine effects on actual driving performance in a standard test: Summary of Dutch experience, 1989-1994. Allergy 50: 234-242
52. O'Hanlon JF, Robbe HW, Vermeeren A, van Leeuwen C, Danjou PE (1998) Venlafaxine's effects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens. J Clin Psychopharmacol 18: 212-221
53. O'Neill D (1998) Benzodiazepines and driver safety. Lancet 352: 1324-1330
54. Pal S, Bhattacharya KF, Agapito C, Chaudhuri KR (2001) A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy. J Neural Transm 108: 71-77
55. Philpot EE (2000) Safety of second generation antihistamines. Allergy Asthma Proc 21: 15-20
56. Ray WA (1997) Safety and mobility of the older driver: A research challenge. JAMA 278: 66-67
57. Ray WA, Fought RL, Decker MD (1992) Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol 136: 873-883
58. Ray WA,Thapa PB, Shorr RI (1993) Medications and the older driver. Clin Geriatr Med 9: 413-438
59. Sanner B, Sturm A (1997) Therapie der schlafstörungen im alter. Dtsch Med Wochenschr 122: 1599-1604
60. Schwab M, Röder F, Ammon S, Thon KP, Mörike K (1999) Increased number of hip fractures. Lancet 353: 2160
61. Sjögren H, Björnstig U, Eriksson A, Öhman U, Solarz A (1997) Drug and alcohol use among injured motor vehicle drivers in Sweden: Prevalence, driver, crash, and injury characteristics. Alcohol Clin Exp Res 21: 968-973
62. Smith AM (1996) Patients taking stable doses of morphine may drive. BMJ 312: 56-57
63. Soyka M, Kagerer S, Gartenmaier A (2001) Verkehrssicherheit bei psychischen störungen. Übersicht und kommentar zu den aktuellen begutachtungsleitlinien zur kraftfahreignung. Nervenheilkunde 20: 511-518
64. Spaeth J, Klimek L, Mosges R (1996) Sedation in allergic rhinitis is caused by the condition and not by antihistamine treatment. Allergy 51: 893-906
65. Strumpf M, Köhler A, Zenz M, Willweber-Strumpf A, Dertwinkel R, Donner B (1997) Opioide und fahrtüchtigkeit. Schmerz 11: 233-240
66. Tanaka E (1999) Clinically significant pharmacokinetic drug interactions with benzodiazepines. J Clin Pharmacy Ther 24: 347-355
67. Vainio A, Ollila J, Matikainen E, Rosenberg P, Kalso E (1995) Driving ability in cancer patients receiving long-term morphine analgesia. Lancet 346: 667-670
68. Weiler JM, Bloomfield JR, Woodworth GG et al. (2000) Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa Driving Simulator. Ann Intern Med 132: 354-363